In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

Nanoparticles that exhibit localization to specific organs or to sites of disease via biological mechanisms, such as the RES or the EPR effect, are known as 'passive targeting agents'. One of the ...

ACA Pharma: team@acapharma.net Azurity Pharmaceuticals: media@azurity.com ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

The recommendation is included in the organization’s “Guidelines for the management of chronic coronary syndromes,” published Aug. 30 in the European Heart Journal. “Ultrasound contrast agents ...

The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...

Curadel Surgical Innovations Inc., a privately held company specializing in the development of near-infrared fluorescent contrast agents for image-guided surgery, today announced a worldwide ...

BR55 was safe and highly accurate (>95%) at marking VEGFR2 expression in patients with breast, ovarian and thyroid cancer, as well as Crohn disease. The Food and Drug Administration (FDA) has granted ...